Page 2145 - Hematology_ Basic Principles and Practice ( PDFDrive )

Chapter 126 Molecular Basis of Blood Coagulation 1905.e1

REFERENCES 29. Williams JC, Mackman N: Tissue factor in health and disease. Front
Biosci (Elite Ed) 4:358, 2012.
1. Brinkhous KM: A short history of hemophilia, with some comments 30. Butenas S, Orfeo T, Brummel-Ziedins KE, et al: Tissue factor in
on the word “hemophilia”. In Brinkhous KM, Hemker HC, editors: thrombosis and hemorrhage. Surgery 142:S2, 2007.
Handbook of hemophilia, New York, 1975, American Elsevier. 31. Nemerson Y: Tissue factor and hemostasis. Blood 71:1, 1988.
2. Ratnoff OD: The evolution of knowledge about hemostasis. In Ratnoff 32. Edgington TS, Mackman N, Brand K, et al: The structural biology
OD, Forbes CD, editors: Disorders of hemostasis, Philadelphia, 1996, of expression and function of tissue factor. Thromb Haemost 66:67,
W.B. Saunders Company, p 1. 1991.
3. Owen CA, Jr: A history of blood coagulation, Rochester, MN, 2001, 33. Nakagaki T, Foster DC, Berkner KL, et al: Initiation of the extrinsic
Mayo Foundation for Medical Education and Research. pathway of blood coagulation: evidence for the tissue factor dependent
4. Owen CA: Older concepts of blood coagulation. In Nichols WL, Bowie autoactivation of human coagulation factor VII. Biochemistry 30:10819,
EJ, editors: A history of blood coagulation, Rochester, MN, 2001, Mayo 1991.
Foundation for Medical Education and Research, p 7. 34. Toomey JR, Kratzer KE, Lasky NM, et al: Targeted disruption of the
5. Morawitz P: Die chemie der blutgerrinnung. Ergebn Physiol 4:307, murine tissue factor gene results in embryonic lethality. Blood 88:1583,
1905. 1996.
6. Wright IS: The nomenclature of blood clotting factors. Thromb Diath 35. Giesen PL, Rauch U, Bohrmann B, et al: Blood-borne tissue factor:
Haemorrh 7:381, 1962. another view of thrombosis. Proc Natl Acad Sci USA 96:2311, 1999.
7. Macfarlane RG: An enzyme cascade in the blood clotting mechanism, 36. Santucci RA, Erlich J, Labriola J, et al: Measurement of tissue factor
and its function as a biochemical amplifier. Nature 202:498, 1964. activity in whole blood. Thromb Haemost 83:445, 2000.
8. Davie EW, Ratnoff OD: Waterfall sequence for intrinsic blood clotting. 37. Osterud B: The role of platelets in decrypting monocyte tissue factor.
Science 145:1310, 1964. Semin Hematol 38:2, 2001.
9. Oldenburg J, Marinova M, Muller-Reible C, et al: The vitamin K cycle. 38. Zillmann A, Luther T, Muller I, et al: Platelet-associated tissue factor
Vitam Horm 78:35, 2008. contributes to the collagen-triggered activation of blood coagulation.
10. Brenner B, Kuperman AA, Watzka M, et al: Vitamin K-dependent Biochem Biophys Res Commun 281:603, 2001.
coagulation factors deficiency. Semin Thromb Hemost 35:439, 2009. 39. Butenas S, Bouchard BA, Brummel-Ziedins KE, et al: Tissue factor
11. Chatrou ML, Reutelingsperger CP, Schurgers LJ: Role of vitamin activity in whole blood. Blood 105:2764, 2005.
K-dependent proteins in the arterial vessel wall. Hamostaseologie 31:251, 40. Morel O, Toti F, Hugel B, et al: Procoagulant microparticles: disrupt-
2011. ing the vascular homeostasis equation? Arterioscler Thromb Vasc Biol
12. Nelsestuen GL, Shah AM, Harvey SB: Vitamin K-dependent proteins. 26:2594, 2006.
Vitam Horm 58:355, 2000. 41. Falati S, Liu Q, Gross P, et al: Accumulation of tissue factor into
13. Berkner KL: Vitamin K-dependent carboxylation. Vitam Horm 78:131, developing thrombi in vivo is dependent upon microparticle P-selectin
2008. glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197:1585,
14. Bandyopadhyay PK: Vitamin K-dependent gamma- 2003.
glutamylcarboxylation: an ancient posttranslational modification. 42. Chou J, Mackman N, Merrill-Skoloff G, et al: Hematopoietic cell-
Vitam Horm 78:157, 2008. derived microparticle tissue factor contributes to fibrin formation
15. Nelsestuen GL, Kisiel W, Di Scipio RG: Interaction of vitamin K during thrombus propagation. Blood 104:3190, 2004.
dependent proteins with membranes. Biochemistry 17:2134, 1978. 43. Esmon NL, Owen WG, Esmon CT: Isolation of a membrane-bound
16. Schwalbe RA, Ryan J, Stern DM, et al: Protein structural require- cofactor for thrombin-catalyzed activation of protein C. J Biol Chem
ments and properties of membrane binding by gamma-carboxyglutamic 257:859, 1982.
acid-containing plasma proteins and peptides. J Biol Chem 264:20288, 44. Fukudome K, Esmon CT: Identification, cloning, and regulation of
1989. a novel endothelial cell protein C/activated protein C receptor. J Biol
17. Schulman S, El Bouazzaoui B, Eikelboom JW, et al: Clinical factors Chem 269:26486, 1994.
influencing the sensitivity to warfarin when restarted after surgery. J 45. Bangalore N, Drohan WN, Orthner CL: High affinity binding sites for
Intern Med 263:412, 2008. activated protein C and protein C on cultured human umbilical vein
18. Lurie Y, Loebstein R, Kurnik D, et al: Warfarin and vitamin K intake endothelial cells. Independent of protein S and distinct from known
in the era of pharmacogenetics. Br J Clin Pharmacol 70:164, 2010. ligands. Thromb Haemost 72:465, 1994.
19. Cosgriff SW: The effectiveness of an oral vitamin K in controlling 46. Esmon CT: Inflammation and the activated protein C anticoagulant
excessive hypothrombinemia during anticoagulant therapy. Ann Intern pathway. Semin Thromb Hemost 32:49, 2006.
Med 45:14, 1956. 47. Rezaie AR: Regulation of the protein C anticoagulant and antiinflam-
20. Stafford DW: The vitamin K cycle. J Thromb Haemost 3:1873, 2005. matory pathways. Curr Med Chem 17:2059, 2010.
21. Garcia AA, Reitsma PH: VKORC1 and the vitamin K cycle. Vitam 48. Hofsteenge J, Taguchi H, Stone SR: Effect of thrombomodulin on the
Horm 78:23, 2008. kinetics of the interaction of thrombin with substrates and inhibitors.
22. Hirsh J: Optimal intensity and monitoring warfarin. Am J Cardiol Biochem J 237:243, 1986.
75:39B, 1995. 49. Bourin MC, Boffa MC, Bjork I, et al: Functional domains of rabbit
23. Hirsh J, Dalen J, Anderson DR, et al: Oral anticoagulants: mechanism thrombomodulin. Proc Natl Acad Sci USA 83:5924, 1986.
of action, clinical effectiveness, and optimal therapeutic range. Chest 50. Preissner KT, Delvos U, Muller-Berghaus G: Binding of thrombin to
119:8S, 2001. thrombomodulin accelerates inhibition of the enzyme by antithrombin
24. Joseph DR, Baker ME: Sex hormone-binding globulin, androgen- III. Evidence for a heparin-independent mechanism. Biochemistry
binding protein, and vitamin K-dependent protein S are homologous to 26:2521, 1987.
laminin A, merosin, and Drosophila crumbs protein. FASEB J 6:2477, 51. Kalafatis M, Rand MD, Mann KG: The mechanism of inactivation of
1992. human factor V and human factor Va by activated protein C. J Biol
25. Prowse CV, Esnouf MP: The isolation of a new warfarin-sensitive Chem 269:31869, 1994.
protein from bovine plasma. Biochem Soc Trans 5:255, 1977. 52. Eaton D, Rodriguez H, Vehar GA: Proteolytic processing of human
26. Mann KG, Nesheim ME, Church WR, et al: Surface-dependent reac- factor VIII. Correlation of specific cleavages by thrombin, factor Xa,
tions of the vitamin K-dependent enzyme complexes. Blood 76:1, 1990. and activated protein C with activation and inactivation of factor VIII
27. Nemerson Y, Repke D: Tissue factor accelerates the activation of coagulant activity. Biochemistry 25:505, 1986.
coagulation factor VII: the role of a bifunctional coagulation cofactor. 53. Nesheim M: Fibrinolysis and the plasma carboxypeptidase. Curr Opin
Thromb Res 40:351, 1985. Hematol 5:309, 1998.
28. Butenas S, Orfeo T, Mann KG: Tissue factor in coagulation: Which? 54. Bajzar L, Jain N, Wang P, et al: Thrombin activatable fibrinolysis inhibi-
Where? When? Arterioscler Thromb Vasc Biol 29:1989, 2009. tor: not just an inhibitor of fibrinolysis. Crit Care Med 32:S320, 2004.